DPP-IV Inhibitory Potentials of Flavonol Glycosides Isolated from the Seeds of Lens culinaris: In Vitro and Molecular Docking Analyses
Dipeptidyl peptidase IV (DPP-IV), a new target for the treatment of type 2 diabetes mellitus, degrades incretins such as glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide. DPP-IV inhibitors shorten the inactivation of GLP-1, permitting the incretin to stimulate insulin...
Main Authors: | Bo-Ram Kim, Hyo Young Kim, Inhee Choi, Jin-Baek Kim, Chang Hyun Jin, Ah-Reum Han |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-08-01
|
Series: | Molecules |
Subjects: | |
Online Access: | http://www.mdpi.com/1420-3049/23/8/1998 |
Similar Items
-
Computational Modeling of the Interactions between DPP IV and Hemorphins
by: Priya Antony, et al.
Published: (2024-03-01) -
Two New Acylated Flavonol Glycosides from the Seeds of Lepidium sativum
by: Qing-Lu Fan, et al.
Published: (2014-07-01) -
Antioxidative, Anti-Inflammatory, and Anticancer Effects of Purified Flavonol Glycosides and Aglycones in Green Tea
by: Chan-Su Rha, et al.
Published: (2019-08-01) -
Dipeptidyl peptidase IV and its implication in cancer
by: Yarini M Arrebola, et al. -
Identification and dipeptidyl peptidase IV (DPP-IV) inhibitory activity verification of peptides from mouse lymphocytes
by: Juan Wang, et al.
Published: (2022-11-01)